SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC
Shandong Provincial Hospital
Shandong Provincial Hospital
Servicio de Salud Metropolitano Sur Oriente
Fujian Cancer Hospital
Medical Research Council
Instituto Nacional de Cancer, Brazil
Instituto Nacional de Cancer, Brazil
National Cancer Center, Korea
National Cancer Institute, France
National Cancer Center, Korea
National Cancer Center, Korea
Tel-Aviv Sourasky Medical Center
Tata Memorial Hospital
National Cancer Center, Korea
National Cancer Center, Korea